N atural regulatory T cells (nTregs)
3 that are generated in the thymus are essential throughout life for maintenance of T cell homeostasis and prevention of autoimmunity (1) . They are defined by expression of the transcription factor FoxP3, in addition to surface phenotypic markers that are not restricted to regulatory T cells (Tregs), such as CD4, CD25, GITR, and CTLA4. Major research efforts have been devoted to understanding both the mechanisms of suppression by Tregs and the molecular events that determine the development of nTregs in the thymus. Expression of FoxP3 is essential for Tregs' suppressive function of genetic inactivation. Neonatal deletion of FoxP3 results in aggressive lymphoproliferation and rapid animal death (2, 3) . In contrast, FoxP3 is not needed for Treg thymic development per se, as cells of the Treg lineage do develop in mice that express nonfunctional FoxP3, albeit lacking suppressor function (4, 5) .
The signaling events necessary for nTreg development in the thymus are not fully understood. Three main signals have been identified, namely those generated by the TCR, by costimulatory molecules, and by cytokines. First, TCR engagement is needed for generation of nTregs in the thymus. It is thought that self-Ag recognition by the TCR is required with an affinity intermediate between that necessary for positive selection of conventional T cells and that needed for deletion of autoreactive T cells (6) . However, whether this is due to instruction of uncommitted precursors with higher TCR affinity to become Tregs or because of higher resistance to apoptosis of precommitted Treg precursors (7) is not clear. Second, costimulatory signals play an important role because mice deficient in CD28, its ligands CD80 and CD86, or CD40, or LFA1 display markedly reduced numbers of nTregs (1, 8 -10) . Third, IL-2, in combination with IL-15 or IL-7, is also crucial for nTreg development. Whereas single absence of IL-2 or CD25 (the IL-2R␣-chain) mildly impacts thymic nTreg development (11) (12) (13) , mice lacking both IL-2 and IL-15, or CD122 (the IL-2␤R chain common to both IL-2 and IL-15 receptor), or CD132 (the common ␥-chain), or STAT5a/b (the transcription factor downstream of IL-2R) are all devoid of nTregs (13) (14) (15) (16) (17) (18) (19) . Conversely, transient or transgenic expression of STAT5 can rescue nTreg numbers in mice deficient in IL-2, CD25, CD122 or CD132 (13, 15, 20, 21) .
Based on these and other data, two models of nTreg thymic development have been put forth that are not necessarily mutually exclusive. First, a two-step model of nTreg development has been proposed (15, 22) , in which an initial TCR-mediated signal enables Treg precursors to become responsive to ␥c cytokines. Subsequent exposure of these precursor cells to IL-2 in the absence of new TCR ligation results in their differentiation into mature nTregs. The second model postulates that precommitted Treg precursors are resistant to strong TCR signal-mediated apoptosis at a stage preceding negative selection. Therefore, strong TCR avidity results in negative selection of precursors to conventional T cells, but drives survival of Treg precursors and further maturation into Tregs (7, 23) . Two putative precursor populations of nTregs have been described. The most proximal one comprises CD4CD8 double-positive (DP) thymocytes that express FoxP3 (24) . This population can develop into mature Tregs if transferred into recipient hosts (25) . A more distal precursor population is found among CD4 singlepositive (SP) thymocytes and expresses CD25, CD122, and GITR but lacks FoxP3 until exposed to IL-2 (22) . Whether the proximal precursor gives rise to the distal one before nTreg generation is not known. The signals required for the development of these precursors have not been defined.
The molecular circuitry by which TCR signals enable nTreg development is not fully understood. Engagement of the TCR leads to activation of protein kinase C (PKC)-that triggers assembly of an adaptor complex containing CARMA1, Bcl10, and Malt-1 (26, 27) , commonly termed the CBM complex for the initials of its partners (28) . Association and activation of the CBM complex is necessary for NF-B activation (28, 29) . Mice deficient in PKC-, lacking Bcl10 or CARMA1, or bearing a conditional deletion of IB kinase ␤ (IKK␤) at the DP stage in T cells display normal development of conventional T cells but a substantial reduction or absence of thymic nTregs (30 -34) . The mechanism by which TCR-NF-B activation promotes nTreg development remains to be explained. It has been hypothesized that the CBM complex/TCR-NF-B is required in a Treg-extrinsic manner, because mature T cells from PKC--knockout (KO), Bcl10-KO, CARMA1-KO, and IKK␤-conditional KO animals are impaired in their ability to produce IL-2 and other putative factors necessary for nTreg development (35) . In addition, the two models of nTreg development described above postulate a step of Treg-specific TCR engagement downstream from commitment to the Treg lineage, for either responsiveness to ␥c cytokines or resistance to apoptosis. Whether CBM/NF-B activation is required for these developmental steps is not known.
In this study, we sought to investigate the mechanism by which the CBM complex controls nTreg development. To address this question, we used CARMA1-deficient mice (36) because expression of CARMA1 is restricted to lymphoid cells, whereas Bcl10 and Malt-1 are more widely expressed (28) . We found that CARMA1 acts in a Treg-intrinsic rather than -extrinsic manner and is required for the generation of thymic precursors upstream of Tregs, thus controlling an early checkpoint in Treg development.
Materials and Methods

Mice
CARMA1-deficient mice (36) , originally generated on the 129 background (H-2 b ) were a gift from Dr. Daniel Littman (New York University, New York, NY) and were backcrossed for six generations to the C57BL/6 background (H-2 b ) at University of Chicago specific pathogen-free barrier facility. Control littermates or C57BL/6 (B6) mice were used as wild-type mice. FoxP3 gfp knockin mice that expressed FoxP3 as a FoxP3-GFP fusion protein were obtained from Alexander Rudensky (University of Washington, Seattle, WA) (11) and backcrossed to B6 mice for eight generations. Generation of mice expressing a constitutively active form of STAT5 in lymphocytes (STAT5-CA) was previously described (21) . FoxP3-deficient (Scurfy (Sf), CD45.1/CD45.2) bone marrow was provided by Steven Ziegler (Benaroya Research Institute, Seattle, WA). Bcl-2-transgenic (Tg) mice under control of a Vav promoter were obtained from Dr. Fotini Gounari (University of Chicago, Chicago, IL) and crossed to CARMA1-KO. Rat insulin promoter (RIP)-membrane OVA Tg mice on a B6 background were purchased from The Jackson Laboratory. OVA-specific OTII TCR Tg B6 wildtype and CARMA1-KO mice were bred at the University of Chicago. All the experiments were performed in agreement with our Institutional Animal Care and Use Committee and according to the National Institutes of Health guidelines for animal use.
Flow cytometry
Single-cell suspensions generated from the thymus, peripheral blood, spleen, and lymph nodes of mice were stained and analyzed by six-color flow cytometry using standard surface staining (CD4, CD8␣, CD25, GITR, CD122, and CD44) or intracellular staining (CTLA-4, FoxP3) techniques., and analyzed in BD FACSCanto and LSR II flow cytometers. Fluorochrome-conjugated Abs were obtained from e-Bioscience (FoxP3, GITR) or BD Pharmingen (all others).
Bone marrow reconstitution experiments
Bone marrow cells (5 ϫ 10 6 ) were isolated from the femurs and tibias of three week-old donor mice (CD45.1/CD45.2/Thy1.2 Sf, CD45.2/Thy1.1/ Thy1.2 CARMA1-KO, or CD45.2/Thy1.1 B6). T cells were depleted by magnetic bead separation following labeling with anti-Thy1.2-biotin (for Thy1.2 ϩ cells) or anti-CD4/CD8-biotin (for Thy1.1 ϩ cells) Abs (BD Pharmingen) and incubation with streptavidin-coupled Dynabeads (Dynal Biotech). Effective depletion was verified by flow cytometry. The remaining cells were injected i.v. in the indicated combinations into syngeneic RAG1-deficient mice that had been sublethally irradiated (600 rads) 4 -24 h earlier. Ten weeks later, mice were sacrificed and thymi, spleens, and lymph nodes were analyzed by flow cytometry. Bone marrow from OTII wild-type (Thy1.1) and OTII CARMA1-KO (Thy1.1/Thy1.2) was T celldepleted as described above and injected i.v. into syngeneic RIP-membrane OVA-Tg mice that had been lethally irradiated (1050 rads) 24h earlier. Six weeks later mice were sacrificed and thymi and spleens were analyzed by flow cytometry.
IL-2 reconstitution experiments
Wild-type and CARMA1-KO mice received daily i.v. injections of a combination of mouse IL-2 (1.5 g/day, eBioscience) and anti-mouse IL-2 mAb (clone JES6 -1A12, BioXCell, 50 g/day) for 7-9 days. Thymi, spleens, and lymph nodes were analyzed on days 8 -10 by flow cytometry.
nTreg precursor purification
Thymocytes from Foxp3 gfp mice were labeled with anti-CD8 microbeads (Miltenyi Biotech), and CD8 ϩ cells were then depleted by magnetic bead separation. The remaining cells were stained with directly conjugated fluorescent Abs to CD4, CD8, CD25, and GITR and sorted by flow cytometry for the indicated populations using a FACSAria high speed flow cytometry cell sorter (BD Pharmingen). Purity was greater than 99%. Cells were incubated for 24 h in the presence or absence of IL-2 (20 U/ml) and expression of FoxP3 was analyzed by flow cytometry.
Statistical analysis
Statistical significance was evaluated using the two-tailed unpaired t test. Values of p Ͻ 0.05 was considered significant.
Results
CARMA1 is necessary for the generation of nTregs and functional suppressor cells
To investigate the involvement of the CBM complex in the development of nTregs, we used mice deficient in CARMA1, an adaptor predominantly expressed in lymphoid cells (37, 38) . Both thymi and splenocytes from CARMA1-deficient mice lacked Tregs as defined by expression of CD4 (Fig. 1A) , suggesting a deficiency in the complete nTreg lineage rather than a selective inability to up-regulate FoxP3. The Treg lineage remained absent in older mice (Fig. 1B) , indicating that this was a persistent defect not compensated over time. In contrast, the proportion (Fig. 1A ) and total number (data not shown) of conventional CD4 ϩ and CD8 ϩ T cells were normal, as were those of NKT cells (data not shown). These results indicate that CARMA1-deficient mice have a selective defect in the thymic development of nTregs.
It has been previously shown that forced expression of Ag on medullary thymic epithelial cells (mTECs) can rescue development of nTregs in cases of T cells with low TCR affinity. This can be achieved using the rat insulin promoter (RIP) that drives expression of genes not only in pancreatic ␤ cells but also in mTECs (39) . To determine whether forced expression of Ag on mTECs would rescue development of Ag-specific CARMA1-KO T cells, we developed a bone marrow chimeric system. RIP-driven OVAexpressing mice or control mice were lethally irradiated and reconstituted with bone marrow from mice expressing an OVA-specific OTII TCR transgene on either the wild-type or CARMA1-KO background. CARMA1-competent T cells bearing the OTII TCR (V␣2 ϩ V␤5.1 ϩ ) failed to express FoxP3 in control recipients, in contrast to a normal proportion of those with rearrangement of an endogenous TCR␣-chain (Fig. 2) . Consistent with published reports (39), expression of OVA under the control of the RIP rescued thymic development of wild-type OTII nTregs, as determined both by percentage and total number of thymic Tregs (Fig. 2) , whereas it did not affect development of non OTII T cells using endogenous ␣-chain rearrangements (Fig. 2) . However, CARMA1-deficient OTII cells failed to express FoxP3 in RIP-OVA Tg mice (Fig. 2) , indicating that CARMA1 expression is essential for development of either polyclonal or Ag-restricted Tregs.
Lack of T cells with an nTreg phenotype may not necessarily mean lack of cells with regulatory function. To test whether CARMA1-KO mice developed cells with suppressor function but a phenotype different from classical nTregs, we generated mixed bone marrow chimeras using RAG1-deficient mice reconstituted with FoxP3-deficient Sf bone marrow mixed with either CARMA1-KO or wild-type bone marrow at a 1:1 ratio. As expected, RAG1-KO mice reconstituted with Sf bone marrow alone that cannot give rise to nTregs died within 5 wk after transplantation, whereas recipient mice receiving a mixture of Sf and wild-type bone marrow, in which wild-type bone marrow cells generate nTregs that compensate for the Sf genetic defect, survived indefinitely and remained healthy (Table I ). In contrast, all but one recipient reconstituted with a mixture of Sf and CARMA1-KO bone marrow succumbed a few weeks after a Irradiated RAG1-KO mice were reconstituted with Sf, CARMA1-deficient, or wild-type bone marrow alone or in combination at a 1:1 ratio and animal survival was assessed.
b Unlike the five other animals in this group, the surviving mouse had negligible levels of hematopoietic Sf CD45.1 cells, suggesting failure to engraft by the Sf bone marrow. transplantation (Table I, the Sf bone marrow had failed to engraft in the surviving mouse), indicating that CARMA1-KO mice lack hematopoietic cells with functional regulatory capacity sufficient to compensate for absence of classical nTregs.
Lack of nTreg development in CARMA1-KO mice is Treg-intrinsic
It has been postulated that lack of nTregs in Bcl10-KO and IKK␤-conditional KO mice is due to insufficient production by conventional T cells of factors such as IL-2 that are important for development of nTregs (35) . As CARMA1-KO conventional T cells also displayed reduced IL-2 production upon TCR stimulation (Supplemental Fig. 1 ), 4 we tested whether lack of nTregs in CARMA1-KO mice was due to diminished availability of IL-2. Wild-type and CARMA1-KO mice were treated for 7-9 days with a combination of mouse IL-2 plus anti-IL-2 Abs, a regimen previously described to promote the proliferation of wild-type peripheral Tregs (40) (Supplemental Fig. 2) . However, exogenous IL-2 did not restore detectable percentages of FoxP3 ϩ cells in the thymus of CARMA1-KO mice (Fig. 3A) , suggesting that the defect in nTreg development is not solely due to lower IL-2 levels in these mice.
As an alternative approach and to determine whether other factors, in addition to IL-2, produced by wild-type hematopoietic cells could restore nTreg development and/or survival, mixed bone marrow chimeras were generated. A mixture of wild-type and CARMA1-deficient bone marrow bearing Thy1.1 and Thy1.1/ Thy1.2 congenic markers, respectively, was injected at a 1:1 ratio into syngeneic RAG1-KO mice. This approach had been shown previously to rescue nTreg numbers in wild-type ϫ IL-2-KO mixed bone marrow chimeras, indicating that 50% IL-2 was sufficient for nTregs to develop (10) . Thymi and spleens were analyzed 10 wk posttransplantation for the presence of CD4 ϩ CD25 ϩ Foxp3 ϩ T cells. Although wild-type Tregs developed normally in this system, neither thymic nor peripheral CARMA1-deficient CD4 ϩ CD25 ϩ Foxp3 ϩ cells were detectable by flow cytometry (Fig. 3, B and C) . In fact, a greater number of wild-type nTregs were observed in recipients of mixed bone marrow compared with those of wild-type bone marrow alone, suggesting that wild-type nTregs compensate for lack of CARMA1-KO nTregs. These results imply that normal activity of conventional wild-type T cells (or other hematopoietic cells) is not sufficient for CARMA1-KO nTreg development. Thus, in contrast to previous speculations, nTregs have an intrinsic rather than extrinsic dependency on the CBM complex for their thymic development. 
The Journal of Immunology
Overexpression of STAT5 fails to rescue nTreg development in CARMA1-KO mice
CARMA1 is downstream of the TCR, and Treg-intrinsic TCR signals are postulated by the nTreg developmental models to either enable developing nTregs to respond to IL-2/IL-15 or to protect them from apoptosis (23) . We first tested whether lack of IL-2 responsiveness was responsible for failure of nTreg development in CARMA1-KO mice. This was plausible, because TCR-CARMA1-dependent activation of NF-B has been shown to promote transcription of CD25 and STAT5 (41, 42) . In mice that cannot respond to IL-2/IL-15, such as CD122-KO or CD132-KO animals, nTreg development could be rescued by T cell-restricted Tg expression of a constitutively active form of STAT5 (13, 15) whose activity bypassed a requirement for expression of the IL-2/ IL-15 receptors. To address whether STAT5 signaling could restore nTreg development in CARMA1-deficient mice, we generated CARMA1-KO animals in which T cells expressed the constitutively active form of STAT5 (CARMA1-KO/STAT5-CA mice). Unlike CD122-KO/STAT5-CA and CD132/STAT5-CA (13, 15) , nTregs did not develop in CARMA1-KO/STAT5-CA mice (Fig. 4A) . Thus, the role of CARMA1 in nTreg development is not solely to enable responsiveness to IL-2/IL-15.
Overexpression of Bcl-2 does not rescue nTreg development in CARMA1-KO mice
An alternative hypothesis is that TCR/CBM signals are required to promote survival of the developing nTregs, as TCR-NF-B drives expression of pro-survival Bcl-2 family members (43) . To determine whether the mechanism by which CARMA1 expression allowed nTreg development was via protection from cell death, CARMA1-deficient mice were crossed with mice overexpressing Bcl-2 in their hematopoietic compartment. In CARMA1-competent mice (CARMA1 ϩ/Ϫ ), Tg expression of Bcl-2 resulted in enhanced development of CD4 ϩ and CD8 ϩ SP thymocytes and a great increase in the total number, but not percentage, of peripheral T cells as previously described (44) (Supplemental Fig. 3 ). However, development of CARMA1-KO nTregs was not rescued by Bcl-2 overexpression (Fig. 4B) , indicating that CARMA1 does not control nTreg development only through inhibition of mitochondrial-dependent cell death.
CARMA1 is necessary for the generation of nTreg precursor populations
As lack of CARMA1-KO nTregs was not rescued by STAT5 and Bcl-2 activity, we postulated that expression of CARMA1 may be required at an earlier developmental checkpoint of nTreg development, namely the generation of nTreg precursors.
Two putative thymic precursor populations of nTregs have been reported. A small percentage of DP thymocytes has been shown to express FoxP3 and give rise to CD4 SP nTregs (10, 24, 25) . This population was small but distinct in wild-type DP thymocytes, whereas it was totally absent from CARMA1-KO DP thymocytes (Fig. 5A) , indicating that CARMA1 is also required for the generation of this proximal precursor population.
A distal precursor has been recently described by Lio and Hsieh (22) within the CD4 SP thymocytes, comprised among the CD4 ϩ CD8␣ Ϫ CD25 int Foxp3 Ϫ GITR high CD122 int HSA int SP population. Using FoxP3 gfp mice, we confirmed that this small (0.4 -3% of CD4SP thymocytes) nTreg putative precursor population was present within the thymus of wild-type mice (Fig. 5B ) but minimally in the spleen (data not shown), and that exposure of this sorted thymic population to exogenous IL-2 resulted in up-regulation of FoxP3 (22) (Supplemental Fig. 4) , whereas IL-2 treatment of the remaining CD4
ϩ FoxP3 Ϫ population (CD25 Ϫ GITR Ϫ ) did not (Supplemental Fig. 4 ). As shown in Fig. 5B,  CD4 ϩ CD25 int GITR high CD122 int cells thought to contain this nTreg precursor population were absent among the CD4 ϩ SP thymocytes from CARMA1-KO mice. To test whether this distal nTreg precursor population was actually present in the CD4SP cells but lacked CD25 and GITR expression and therefore could not be identified, CD4SP cells were sorted and incubated in the presence of IL-2. However, no CARMA1-KO FoxP3 ϩ cells could be detected at 24h (Supplemental Fig. 4 ) or 96h (data not shown).
Thus, CARMA1 appears necessary for the development of the CD4 ϩ CD25 ϩ GITR ϩ FoxP3 Ϫ nTreg precursor population. Together, these results indicate that the requirement for CARMA1 in the generation of nTregs is secondary to the ability of CARMA1 to enable the development of the described nTreg precursor populations and thus CARMA1 controls nTreg development at a proximal checkpoint.
Discussion
Mice with genetic disruptions along the TCR-NF-B pathway have been shown to have defects in the development of nTregs (30, 31) . In particular, selective disruption of the CBM complex, such as in Bcl-10-KO or CARMA1-KO mice, resulted in normal development of conventional CD4 ϩ and CD8 ϩ cells but complete absence of nTregs (30, 32, 34) . This provides a unique model to dissect the requirements that are unique for nTreg development. We used mice deficient in CARMA1, a lymphoidrestricted member of the CBM complex, to understand further the mechanism by which the CBM complex, and thus likely the TCR-NF-B axis, controls the development of nTregs. Similar to Bcl10, we confirmed that CARMA1 expression was needed for the thymic development of nTregs but not of conventional T or NKT cells. It had been hypothesized that defects in nTreg development in mice with impaired T cell-NF-B activation were Treg-extrinsic and due to reduced IL-2 production by conventional T cells (35) . However, in contrast to this hypothesis, we found that CARMA1 was required for the development of nTregs in a cell-intrinsic rather than -extrinsic manner, by enabling the development of thymic Treg precursor populations. These data thus position the TCR/CARMA1 axis as controlling early developmental checkpoints along the path toward thymic nTreg generation.
Our data demonstrate the intrinsic requirement of CARMA1 for the development of nTregs rather than for production by non-Tregs of developmental or survival factors important for nTreg generation. These results are consistent with recent data by Barnes et al. (34) in mice harboring a point mutation in CARMA1 that results in its loss of function. CD28-mediated signals are also required in a Treg-intrinsic manner for Treg development, as mixed bone marrow chimeras of wild-type and CD28-deficient bone marrow failed to rescue development of CD28-KO nTregs (10) . It is interesting to note that the main defect in T cells from mice bearing a point mutation in the coiled-coil domain of CARMA1 is their selective defect in CD28-mediated costimulation (45) . However, mechanisms by which CD28 and CARMA1 drive nTreg development must be at least in part distinct, as Tg expression of constitutively active STAT5 restored nTreg development in CD28-deficient (15) but not in CARMA1-deficient mice.
In addition to enabling TCR-mediated NF-B activation, CARMA1 and Bcl10 have been shown to play a role in JNK2 induction, albeit without affecting TCR-driven AP-1 activation (46) . The respective contribution of NF-B and JNK2 in the ability of CARMA1 or Bcl-10 to drive nTreg development remains to be established.
It may be initially surprising that CARMA1-deficient mice do not develop overt autoimmunity (data not shown) despite lack of nTregs or other functional suppressive cells of hematopoietic origin. The first possibility is that these mice have a defect in the thymic development of conventional T cells that would skew positive and/or negative selection toward a repertoire less prone to autoimmunity. Although we cannot exclude this possibility, the only paper published to date that has examined Ag-specific thymic selection of conventional T cells in CARMA1-KO mice reports normal positive and negative selection in the HY TCR transgenic system (45) . The second possibility is that conventional T cells, although developing in normal numbers in the thymus, harbor a generalized TCR activation defect in the periphery. Our current data strongly argue for this hypothesis. First, CARMA1-KO mice failed to reject cardiac allografts (47), a T cell-dependent event, implying that conventional T cell function is impaired (although they could reject skin grafts that typically elicit a stronger T cell response, indicating that CARMA1-KO T cells are not totally incompetent) (47) . Second, reconstitution of these mice with CARMA1-competent T cells resulted in autoimmunity and animal death (see Table I ). This experiment was performed by generating mixed bone marrow chimera using CARMA1-KO bone marrow mixed with Sf (FoxP3-deficient) bone marrow. The resulting animals lacked Tregs (that did not develop from either the CARMA1-KO or the FoxP3-deficient bone marrow) but had a mixture of FIGURE 6. Proposed model for development of nTregs. Double-negative (DN) thymocytes give rise to DP cells. CARMA1 is necessary for development of the proximal nTreg precursor (DPFoxP3 ϩ ) that likely derives from the DP population, as well as for development of the distal nTreg precursor (among the CD4 SP FoxP3 Ϫ ). Whether this population is generated from the proximal nTreg precursor, from DP FoxP3 Ϫ , or SP FoxP3-thymocytes is not known. Maturation of this distal precursor into nTregs requires IL-2 in the absence of new TCR engagement. Requirements for maturation of the proximal precursor into nTregs remain to be established. nTreg precursors are more resistant to apoptosis following strong TCR engagement than precursors of conventional T cells.
CARMA1-KO and CARMA1-competent conventional T cells, the latter of which could drive autoimmunity. Together, these data suggest that failure to develop autoimmunity in CARMA1-KO mice despite lack of nTregs is due to impaired function of conventional T cells because of intrinsic signaling defects and/or repertoire skewing during thymic development.
Treg TCR signals have been proposed either to induce IL-2 susceptibility in nTreg precursors (15, 22) or to drive development of apoptosis-resistant Treg precursors into nTregs (7). However, neither bypassing IL-2 signals via expression of CA-STAT5 nor promoting cell survival via overexpression of Bcl-2 rescued development of CARMA1-KO nTregs. This is, to our knowledge, the first model of an nTreg developmental defect that is not compensated by these genetic approaches. Although we cannot exclude that CARMA1 also plays a role at these more distal steps in nTreg development, the observation that CARMA1 is required for the development of the two known nTreg precursor populations prompts a revised model of nTreg development in which the CBM complex controls an earlier developmental checkpoint than anticipated (Fig. 6) . It is unlikely that CARMA1 would be required at the double negative (DN) pre-TCR stage of development as pre-TCR␣-KO mice have been shown to develop Tregs (48) . Most likely, it is at the DP or SP stage that CARMA1 commits developing thymocytes into Treg precursors (Fig. 6 ). Whether this is due to restricted expression of CARMA1 to a subset of DP cells or to selective activation of CARMA1 depending on strength or quality of the TCR signal encountered during thymic selection remains to be elucidated.
